Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_assertion type Assertion NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_head.
- NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_assertion wasGeneratedBy ECO_0000203 NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_provenance.
- NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_assertion wasDerivedFrom befree-20150227 NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_provenance.
- NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_assertion SIO_000772 19924441 NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_provenance.
- NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_assertion evidence source_evidence_literature NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_provenance.
- NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_assertion description "[After IL-2 treatment, 9 out of 21 (43%) patients did not develop recurrent tumour within the 1 year of follow-up period.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP492976.RAiG13gkwSKuUbyee3GJ3GKCmM6me7Fs6VFO31cawQwuc130_provenance.